We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-6 of 6

Washington Healthcare Update - Jul 16, 2018
  • McGuireWoods LLP
  • USA
  • July 16 2018

In a two-day markup, the House Ways and Means Committee cleared a number of measures related to health savings accounts and a measure that would


Washington Healthcare Update - Aug 28, 2017
  • McGuireWoods LLP
  • USA
  • August 28 2017

On Aug. 17, Reps. Peter Welch (D-VT) and Elijah Cummings (D-MD) sent letters to seven drug companies in an effort to gather information on profits


Washington Healthcare Update - Jun 19, 2017
  • McGuireWoods LLP
  • USA
  • June 19 2017

Reps. Peter Welch (D-VT) and Gregg Harper (R-MS) introduced a bill designed to close a loophole in the 340B drug program that the congressmen say


Washington Healthcare Update - June 12, 2017
  • McGuireWoods LLP
  • USA
  • June 12 2017

On June 7, the House Energy and Commerce Committee reported out a bill reauthorizing FDA user fee programs for drugs and medical devices in a


Washington Healthcare Update - May 1, 2017
  • McGuireWoods LLP
  • USA
  • May 1 2017

On April 27, House Republican leaders decided to delay a vote on their Obamacare repeal bill until this week at the earliest. After a late-night